Both in Pharmaceuticals
Evommune vs Cartesian Therapeutics
Over the past year EVMN returned −74.6% and RNAC returned −16.8%; their daily moves had a correlation of 0.06.
EVMN −74.6% RNAC −16.8%Growth of $1, one year, split-adjusted
| Metric | EVMN | RNAC |
|---|---|---|
| Price | $5.13 | $6.28 |
| Market cap | $186.2M | $190.0M |
| Today | +0.59% | +1.62% |
| 1 month | −39.6% | −15.2% |
| 6 months | −79.5% | −11.4% |
| Year to date | −70.0% | −12.9% |
| 1 year | — | −30.2% |
| Revenue growth (YoY) | — | −100.0% |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | 128.6× |
| Net cash | $200.4M | $94.8M |
| Dividend yield | — | — |
| Volatility (60d) | 77.5% | 49.4% |
| Short % of float | 16.5% | 15.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).